As a division of Merck, responsibility is one of our core values, along with courage, achievement, respect, integrity and transparency. As a biopharmaceutical leader, Merck Serono places special importance upon responsibility to people. It guides us in our work to research and develop new treatments for diseases with high unmet medical needs. And it inspires us to comply with the highest ethical standards at every level of our organization, ensuring we never lose sight of our commitment to patients, employees and the community.

• More about our responsibility >>

You have to ask yourself a lot of questions in my job. Managing priorities in drug development is never easy, but the resources are finite, even if the needs aren’t. Patients with serious diseases desperately need new therapies. They demand a sense of urgency and our best judgement to act on their behalf. That is an important responsibility

• More about DeeAnn’s story >>

If you're looking for the best partner for your next project, take a good look at Merck Serono. We are proud of our track record of establishing strong collaborative relationships with external partners, sharing complementary ideas, skills and capabilities. Whether it’s an early-stage licensing opportunity, new technology or strategic research alliance, if you wish to work with an organization that values trust, transparency and mutually rewarding relationships, we want to hear from you!

• More about partnerships >>

That’s what I think every time I see my son. He’s given me a whole new understanding of life. And of my work, too. For more than 30 years, I’ve specialized in the science and medical treatment of infertility. At the beginning of my career, I worked with the IVF pioneers in Cambridge and since then, I’ve worked all over the world, from Geneva to Japan. But it wasn’t until my wife and I found out we couldn’t conceive that I understood just what people go through.

• More about Colin’s story >>

Our unwavering focus on specialist therapeutic areas is based on our commitment to making a difference in the lives of patients who need it most. That is why we focus our efforts on developing new treatments for cancer patients, and for people with debilitating diseases like multiple sclerosis, Parkinson’s and lupus. We also provide a portfolio of fertility drugs and cardiometabolic care products, especially in emerging markets where patient need remains high.

• More about Merck Serono >>

Merck Serono is growing to meet the huge patient need in China. And coming to Beijing has given me a chance to grow, too. I began my career as a chemical engineer, but now I manage people and projects in R&D. I’ve seen first hand how this company gives its people opportunities to develop and grow professionally.

• More about Frederique’s story >>

In a word, innovation. New molecular entities (NMEs) are compounds, whether biological or chemical, with the potential to become active ingredients for tomorrow’s medicines. At Merck Serono, the capability to develop and manufacture both types of drug compound with equal expertise is a core strength. Our Technical Operations organization ensures a complete mastery of two very different production technologies: chemical synthesis of small molecules for traditional pharmaceuticals and biotech production of protein therapeutics

• More about Technical Operations >>

In all our clinical trials, the safety of the patient always has utmost priority. And there’s a huge sense of urgency, too. Especially when you’re dealing with cancer patients. You also make special efforts for their comfort.

• More about Melaina’s story >>